Jump to content

Talk:Ibritumomab tiuxetan

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 128.231.88.4 (talk) at 21:37, 27 January 2009 (→‎two different drugs). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

WikiProject iconPharmacology Start‑class Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
StartThis article has been rated as Start-class on Wikipedia's content assessment scale.
MidThis article has been rated as Mid-importance on the project's importance scale.
WikiProject iconMedicine Start‑class Low‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
StartThis article has been rated as Start-class on Wikipedia's content assessment scale.
LowThis article has been rated as Low-importance on the project's importance scale.

Clean!

I have now fixed the grammar mistakes and cleaned this article. I have also put it in the correct category. (72.136.49.4 00:22, 28 December 2005 (UTC))[reply]

Pronunciation

I think it is pronounced EYE-bri-TOOM-oh-mab, not IH-bri-TOOM-oh-mab. Regards, Blake3522 11:45, 20 July 2007 (UTC)[reply]

I've worked on the drug at Biogen Idec for 5+ years, and I've never heard anyone call it anything but IH-bri-TOOM-oh-mab, defined as the mouse antibody without the chelator, tiuxetan. Ibritumomab tixuetan is the antibody+chelator, and when it has an isotope bound to the chelator it becomes either 111In-ibritumomab tixuetan or 90Y-ibritumomab tixuetan. (Or you can just do what we do, and call it all Zevalin.)Wsaville (talk) 18:11, 16 January 2008 (UTC)[reply]

Hi. I've removed the link to ibritumomab, which merely redirects back to this very page. The pronunciation is from an AOL site, I hope that's okay. I asssume they have (or had) the money to do it right, all else about AOL aside. Kenmcl2 15:20, 27 July 2007 (UTC)[reply]

two different drugs

Hi.

In-111 Zevalin and Y-90 Zevalin are two different drugs. The terms "Zevalin" or "Ibritumomab tiuxetan" by themselves do not precisely refer to RIT. They are the cold antibody without the radioactive molecule attached.

Since yttrium emits pure beta radiation, it cannot be used to get a picture with a gamma camera. So the indium version is used instead for the pretreatment image (taken about one week before the tx day). Indium emits some gamma along with beta.

The image is taken to make sure that the drug will go to where it should, and not go to where it shouldn't (e.g., excess amounts to marrow, liver, etc)

Kenmcl2 15:47, 27 July 2007 (UTC)[reply]

same point, so the formula C6382H9830N1672O1979S5499Y111In is wrong, its either Y-90 or In-111 so the MW is also probably wrong.--128.231.88.4 (talk) 21:36, 27 January 2009 (UTC)[reply]